Algernon Pharmaceuticals Inc (AGNPF)

[medchem]

A few points to consider when determining future SP:

Many are already drawing comparisons here to Rem. Ok, the first thing to consider is the efficacy of Rem. Not great. Largely, the price of the stock and the valuation placed on ifenprodil will depend on the efficacy. Aka, how much signal. How much POSITIVE signal specifically. Again, these concepts become abstract but generally, there will be a big difference between a drug that has a 10% versus a 40% reduction in the number of patients progressing to ventilation or acute lung injury or mortality rates.

Second, the price of the drug and the trouble to make it. Immunotherapies are pricey on the market, largely because they are complex and hard to synthesize in mass. Ifenprodil is not a complex organic chemical compound, it's chemical features are basic. That means probably, less costs to produce and hopefully more profit for the company without having to charge as much on the market. So this goes to show, market price doesn't correlated with profit, because you much factor in cost of production. To summarize one more time... cheap production cost = more profit per given market price.